Weizman, Libat
Sharon, Haggai http://orcid.org/0000-0003-1981-658X
Dayan, Lior
Espaniol, Joumana
Brill, Silviu
Nahman-Averbuch, Hadas
Hendler, Talma
Jacob, Giris
Clinical trials referenced in this document:
Documents that mention this clinical trial
Oral Delta-9-Tetrahydrocannabinol (THC) Increases Parasympathetic Activity and Supraspinal Conditioned Pain Modulation in Chronic Neuropathic Pain Male Patients: A Crossover, Double-Blind, Placebo-Controlled Trial
https://doi.org/10.1007/s40263-024-01085-0
Funding for this research was provided by:
Tel Aviv University
Article History
Accepted: 11 March 2024
First Online: 10 April 2024
Declarations
:
: Open access funding provided by Tel Aviv University.
: Libat Weizman, Haggai Sharon, Lior Dayan, Joumana Espaniol, Silviu Brill, Hadas Nahman-Averbuch, Talma Hendler, and Giris Jacob report no competing interests.
: Anonymized data are available upon request by contacting the corresponding author.
: This study was approved by the Tel Aviv Sourasky Medical Center’s Institutional Review Board.
: Written informed consent was obtained from all participants in this trial.
: Not applicable.
: Not applicable.
: LW, TH, HS and GJ conceived and designed the trial. HS, LD and SB recruited and assessed the patients, wrote the clinical study protocol, and participated as acting supervising clinicians during the trials. LW and JE collected the data. HS, LW, HNA and GJ analyzed the data. LW, HS and GJ wrote the manuscript.